Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage
Envoy Medical’s FDA-Approved Esteem® Fully Implanted Active Middle Ear Hearing Device May Now Have an Opportunity to be a Coverable Benefit
WHITE BEAR LAKE, Minnesota, July 31, 2024 (GLOBE NEWSWIRE) — Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announces its support for a new bipartisan Senate bill, titled the Hearing Device Coverage Clarification Act (S.4829), which seeks to clarify that implanted active middle ear hearing devices should be viewed as prosthetics and not subject to the current Medicare hearing aid coverage exclusion. Both the House and Senate now have introduced legislation addressing implanted active middle hearing devices, which Envoy Medical believes will increase the chances of meaningful legislation moving forward and becoming law.